Uremia induces functional incompetence of bone marrow-derived stromal cells

Nephrology Dialysis Transplantation

Volumn 27, Issue 1, 2012, Pages 218-225

  Noh, Hyunjin ^a   Yu, Mi Ra ^a   Kim, Hyun Joo ^a   Jeon, Jin Seok ^a   Kwon, Soon Hyo ^a   Jin, So Young ^a   Lee, Jeeyun ^b   Jang, Jiryeon ^b   Park, Joon Oh ^b   Ziyadeh, Fuad ^c   Han, Dong Cheol ^a   Lee, Hi Bahl ^a  

^a Soonchunhyang University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

angiogenesis; bone marrow derived stromal cells; cardiovascular disease; chronic kidney disease

Indexed keywords

CALVASCULIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN KINASE B; STROMAL CELL DERIVED FACTOR 1ALPHA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW DEPRESSION; CARDIOVASCULAR RISK; CELL AGING; CELL DAMAGE; CELL DYSFUNCTION; CELL FUNCTION; CELL HYPOXIA; CELL MIGRATION; CELL PROLIFERATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UMBILICAL VEIN ENDOTHELIAL CELL; UREMIA;

ANIMALS; ANOXIA; BIOLOGICAL MARKERS; BLOTTING, WESTERN; BONE MARROW; CELL ADHESION; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CXCL12; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; KIDNEY FAILURE, CHRONIC; MALE; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; UREMIA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84863052227     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr267     Document Type: Article

References (44)

1. Collins AJ, Foley RN, Herzog C et al. US Renal Data System 2010 Annual Data Report. Am J Kidney Dis 2011; 57: e1-e526
2. Tonelli M, Wiebe N, Culleton B et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006; 17: 2034-2047 (Pubitemid 44036188)
3. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 1998; 339: 799-805 (Pubitemid 28447453)
4. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305
5. Karnib HH, Ziyadeh FN. The cardiorenal syndrome in diabetes mellitus. Diabetes Res Clin Pract 2010; 89: 201-208
6. Muntner P, He J, Astor BC et al. Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. J Am Soc Nephrol 2005; 16: 529-538 (Pubitemid 41725151)
7. Muntner P, Hamm LL, Kusek JW et al. The prevalence of nontradi-tional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med 2004; 140: 9-17
8. Shlipak MG, Fried LF, Crump C et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 2003; 107: 87-92 (Pubitemid 36070938)
9. Hsu CY, McCulloch CE, Curhan GC. Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol 2002; 13: 504-510 (Pubitemid 34106294)
10. Hayashi SY, Rohani M, Lindholm B et al. Left ventricular function in patients with chronic kidney disease evaluated by colour tissue doppler velocity imaging. Nephrol Dial Transplant 2006; 21: 125-132 (Pubitemid 43057120)
11. Raggi P, Boulay A, Chasan-Taber S et al. Cardiac calcification in adult hemodialysis patients: a link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 2002; 39: 695-701 (Pubitemid 34158168)
12. Blacher J, Safar ME, Guerin AP et al. Aortic pulse wave velocity index and mortality in end-stage renal disease. Kidney Int 2003; 63: 1852-1860 (Pubitemid 36513333)
13. London GM, Guerin AP, Marchais SJ et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18: 1731-1740 (Pubitemid 37098542)
14. Davani S, Marandin A, Mersin N et al. Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model. Circulation 2003; 108: II-253-II-258 (Pubitemid 37099964)
15. Nagaya N, Fujii T, Iwase T et al. Intravenous administration of mes-enchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol 2004; 287: H2670-H2676 (Pubitemid 39557139)
16. Au P, Tam J, Fukumura D et al. Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood 2008; 111: 4551-4558
17. Gnecchi M, He H, Noiseux N et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 2006; 20: 661-669 (Pubitemid 44933310)
18. Kinnaird T, Stabile E, Burnett MS et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004; 109: 1543-1549 (Pubitemid 38420184)
19. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006; 98: 1076-1084 (Pubitemid 44128350)
20. Eliopoulos N, Gagnon RF, Francois M et al. Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failure. J Am Soc Nephrol 2006; 17: 1576-1584 (Pubitemid 43794660)
21. Gagnon R, Gallimore B. Characterization of a mouse model of chronic uremia. Urol Res 1988; 16: 119-126 (Pubitemid 18089121)
22. Okuyama H, Krishnamachary B, Zhou Y et al. Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymal cells is dependent on hypoxia-inducible factor 1. J Biol Chem 2006; 281: 15554-15563 (Pubitemid 43855148)
23. Peister A, Mellad JA, Larson BL et al. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 2004; 103: 1662-1668 (Pubitemid 38268957)
24. Dou L, Bertrand E, Cerini C et al. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int 2004; 65: 442-451 (Pubitemid 38130638)
25. Lin CJ, Wu CJ, Pan CF et al. Serum protein-bound uraemic toxins and clinical outcomes in haemodialysis patients. Nephrol Dial Transplant 2010; 25: 3693-3700
26. Lehr H, Leunig M, Menger M et al. Dorsal skinfold chamber technique for intravital microscopy in nude mice. Am J Pathol 1993; 143: 1055-1062 (Pubitemid 24070548)
27. Alfaro MP, Pagni M, Vincent A et al. The Wnt modulator sFRP2 enhances mesenchymal stem cell engraftment, granulation tissue formation and myocardial repair. Proc Natl Acad Sci USA 2008; 105: 18366-18371
28. Morikawa S, Mabuchi Y, Kubota Y et al. Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J Exp Med 2009; 206: 2483-2496
29. Enomoto A, Takeda M, Tojo A et al. Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity. J Am Soc Nephrol 2002; 13: 1711-1720 (Pubitemid 34700595)
30. Mangi AA, Noiseux N, Kong D et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003; 9: 1195-1201 (Pubitemid 37173705)
31. Shweiki D, Itin A, Soffer D et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843-845
32. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18: 4-25 (Pubitemid 27076453)
33. Carmeliet P, Ferreira V, Breier G et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380: 435-439 (Pubitemid 26102719)
34. Kelly BD, Hackett SF, Hirota K et al. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogen-esis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 2003; 93: 1074-1081 (Pubitemid 37485038)
35. Ceradini DJ, Kulkarni AR, Callaghan MJ et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004; 10: 858-864 (Pubitemid 39070860)
36. Peled A, Grabovsky V, Habler L et al. The chemokine SDF-1 stimulates integrin-mediated arrest of CD341 cells on vascular endothelium under shear flow. J Clin Invest 1999; 104: 1199-1211 (Pubitemid 29536291)
37. Askari AT, Unzek S, Popovic ZB et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003; 362: 697-703 (Pubitemid 37101067)
38. Hu X, Dai S, Wu WJ et al. Stromal cell derived factor-1a confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1a CXCR4 axis. Circulation 2007; 116: 654-663 (Pubitemid 47356350)
39. Zhang M, Mal N, Kiedrowski M et al. SDF-1 expression by mesen-chymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J 2007; 21: 3197-3207 (Pubitemid 47565538)
40. Zaruba M, Theiss H, Vallaster M et al. Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. Cell Stem Cell 2009; 4: 313-323
41. Ito K, Hirao A, Arai F et al. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med 2006; 12: 446-451
42. Zhang Y, Herbert BS, Rajashekhar G et al. Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-a via the p38 mitogen-activated protein kinase pathway. FASEB J 2009; 23: 1358-1365
43. Chang J, Li Y, Huang Y et al. Adiponectin prevents diabetic premature senescence of endothelial progenitor cells and promotes endothelial repair by suppressing the p38 MAP kinase/p16INK4A signaling pathway. Diabetes 2010; 59: 2949-2959
44. Golestaneh L, Melamed ML, Hostetter TH. Uremic memory: the role of acute kidney injury in long-term outcomes. Kidney Int 2009; 76: 813-814